MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jhep.2010.01.034

Медицинская библиотека · Journal of hepatology · 2010

Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Pawlikowska Ludmila, Strautnieks Sandra, Jankowska Irena, Czubkowski Piotr, Emerick Karan, Antoniou Anthony, Wanty Catherine, Fischler Bjorn, Jacquemin Emmanuel, Wali Sami, Blanchard Samra, Nielsen Inge-Merete, Bourke Billy, McQuaid Shirley, Lacaille Florence, Byrne Jane A, van Eerde Albertien M, Kolho Kaija-Leena, Klomp Leo, Houwen Roderick, Bacchetti Peter, Lobritto Steven, Hupertz Vera, McClean Patricia, Mieli-Vergani Giorgina, Shneider Benjamin, Nemeth Antal, Sokal Etienne, Freimer Nelson B, Knisely A S, Rosenthal Philip, Whitington Peter F, Pawlowska Joanna, Thompson Richard J, Bull Laura N

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND & AIMS: Progressive familial intrahepatic cholestasis (PFIC) with normal serum levels of gamma-glutamyltranspeptidase can result from mutations in ATP8B1 (encoding familial intrahepatic cholestasis 1 [FIC1]) or ABCB11 (encoding bile salt export pump [BSEP]). We evaluated clinical and laboratory features of disease in patients diagnosed with PFIC, who carried mutations in ATP8B1 (FIC1 deficiency) or ABCB11 (BSEP deficiency). Our goal was to identify features that distinguish presentation and course of these two disorders, thus facilitating diagnosis and elucidating the differing consequences of ATP8B1 and ABCB11 mutations.

METHODS

A retrospective multi-center study was conducted, using questionnaires and chart review. Available clinical and biochemical data from 145 PFIC patients with mutations in either ATP8B1 (61 "FIC1 patients") or ABCB11 (84 "BSEP patients") were evaluated.

RESULTS

At presentation, serum aminotransferase and bile salt levels were higher in BSEP patients; serum alkaline phosphatase values were higher, and serum albumin values were lower, in FIC1 patients. Elevated white blood cell counts, and giant or multinucleate cells at liver biopsy, were more common in BSEP patients. BSEP patients more often had gallstones and portal hypertension. Diarrhea, pancreatic disease, rickets, pneumonia, abnormal sweat tests, hearing impairment, and poor growth were more common in FIC1 patients. Among BSEP patients, the course of disease was less rapidly progressive in patients bearing the D482G mutation.

CONCLUSIONS

Severe forms of FIC1 and BSEP deficiency differed. BSEP patients manifested more severe hepatobiliary disease, while FIC1 patients showed greater evidence of extrahepatic disease.

Для цитирования: Pawlikowska Ludmila, Strautnieks Sandra, Jankowska Irena, Czubkowski Piotr, Emerick Karan, Antoniou Anthony, Wanty Catherine, Fischler Bjorn, Jacquemin Emmanuel, Wali Sami, Blanchard Samra, Nielsen Inge-Merete, Bourke Billy, McQuaid Shirley, Lacaille Florence, Byrne Jane A, van Eerde Albertien M, Kolho Kaija-Leena, Klomp Leo, Houwen Roderick, Bacchetti Peter, Lobritto Steven, Hupertz Vera, McClean Patricia, Mieli-Vergani Giorgina, Shneider Benjamin, Nemeth Antal, Sokal Etienne, Freimer Nelson B, Knisely A S, Rosenthal Philip, Whitington Peter F, Pawlowska Joanna, Thompson Richard J, Bull Laura N. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.. Journal of hepatology. 2010. DOI: 10.1016/j.jhep.2010.01.034.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.